FGF19 and neoplasm: Abnormal expression of FGF19-FGFR4 has been shown to accelerate hepatocarcinogenesis and metastasis, while inhibition of the FGF19/FGFR pathway augments tumor-suppressive activity and improves the prognosis in patients with HCC14,15.